Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thomas F. Wilson
Institution:
Molecular Templates (United States)
Observed institution:
Molecular Templates (United States)
ORCID:
0000-0002-2658-4820
Observed ORCID:
0000-0002-2658-4820
OpenAlex ID:
A5013704079
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
2021
·
Aparna Hegde
, Priyamvada Jayaprakash
, et al.
·
Clinical Cancer Research
·
63
Supplementary Data from A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
2023
·
Aparna Hegde
, Priyamvada Jayaprakash
, et al.
Data from A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
2023
·
Aparna Hegde
, Priyamvada Jayaprakash
, et al.
Data from A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
2023
·
Aparna Hegde
, Priyamvada Jayaprakash
, et al.
Show more works
View as search
Works count:
4
Citation count:
63
H-index:
1
I10-index:
1
Year
Topic
Type